What Pharmacists Need to Know About Suzetrigine for Pain Management
Madison Irwin, PharmD, BCPS, discusses the importance of suzetrigine’s approval in the pain management space and potential challenges or barriers in its adoption.
New Drug Review: FDA Approves Tryvio for the Treatment of Hypertension in Combination With Other Antihypertensive Drugs to Lower Blood Pressure
Tryvio was given FDA approval on March 19, 2024.
OTC Roundup: Digestive Health Products
Help your patients overcome tummy troubles with trusted OTC products that relieve bloating, heartburn, and more, promoting smooth and happy digestion.
Non-Oral Therapies Have Made Significant Progress in Treating Shingles Pain
Researchers conducted a review of clinical studies to better understand non-oral drugs for the treatment of pain related to herpes zoster.
Social Media Could Be Utilized for Self-Care Messaging, Diabetes Education
Social media can help close the gap on health care information access, but pharmacists still play a large role in diabetes management, especially in therapeutics.
Weight Loss, Lipid Changes Could Point Towards Dementia Risk
Poor cardiometabolic health is associated with cognitive impairment in later life, but there is no clear association between cardiometabolic trajectories and early markers.
Q&A: Tips for Integrating Maternity Care Services Into the Pharmacy
Natalie DiPietro Mager, PharmD, PhD, discusses the best ways to integrate maternal health services into the routine workflow of community pharmacies.
Adults with Chronic Pain Support Cannabis Use More Than Physicians
Researchers asked adults with chronic pain and physicians their opinions on cannabis regulations.
What To Know: FDA Approves Apomorphine for Parkinson Disease
Expert highlights the benefits of using apomorphine infusion to provide more consistent medication levels and reduce the unpredictable fluctuations.
Reducing Opioid Prescriptions for Lower Back Pain Increases NSAID, Paracetamol Use
Reducing the number of opioid prescriptions for patients with lower back pain did not result in an increased use of other, risky pain medications.
FDA Grants Fast Track Designation to Rezpegaldesleukin for Atopic Dermatitis
Data from a previous phase 1b trial show improvements in the Eczema Area and Severity Index (EASI)-75 compared with the placebo at 12 weeks.
Lifestyle Management Showed Minimal Improvements for Chronic Low Back Pain
Assessing the management of chronic low back pain, researchers compared outcomes of healthy lifestyle care with current guideline-recommended care.
Rabies srRNA Vaccine Demonstrates Robust Immune Response
RBI-4000 is a self-replicating RNA (srRNA) vaccine developed to stimulate virus-neutralizing immune responses to rabies for prophylactic use.
Majority of People Support Pharmacist Prescribed Hormonal Contraceptives
Investigators from the University of Rhode Island College of Pharmacy discuss 2 studies that assessed perspectives on pharmacist prescribed hormonal contraceptives.
APhA Platform Aims to Tackle Pharmacy Workforce Shortage
The American Pharmacists Association announced the launch of its transformative HealthShifts platform in collaboration with the California Pharmacists Association and powered by Locumate.
Mirikizumab Demonstrates Sustained Clinical, Endoscopic Outcomes for Crohn Disease
Patients who achieved clinical remission at 1 year in VIVID-1 maintain clinical remission at 92.9% at 2 years with the Crohn Disease Activity Index.
Critical Knowledge Gap in Managing Chronic Pain Among Patients with AxSpA
Researchers addressed unmet needs in the treatment of chronic pain for patients living with axial spondyloarthritis.
Many Americans Trust Health Care Providers, Scientific Researchers
The survey results show 1 in 4 Americans ranked health care access and affordability as their highest public health priority for government officials to address.
Dead Birds on Lake Michigan Shore Raise Bird Flu Concerns in Chicago
Experts believe a bird flu outbreak is responsible for hundreds of dead birds washing ashore on the beaches of Chicago.
Team-Based Care Crucial in Addressing Workforce Shortages
Jonathan Watanabe, PharmD, MS, PhD, BCGP, discussed gaps within primary care in the context of the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.
NSAIDs Provided Most Benefits, Least Harm in Treating Pediatric Acute Pain
In a network meta-analysis, researchers compared the safety and efficacy of available analgesic treatment for treating acute pain in children.
Cannabis Use Does Not Predict Relief in Patients With Chronic Pain
A recent study found that edible or smoked cannabis use predicted little variability in pain relief.
FDA Grants Priority Review to Brensocatib for Non-Cystic Fibrosis Bronchiectasis
With the acceptance of the new drug application and granting priority review, the target action date is August 12, 2025.
FDA Alerts of Potential Missed Safety Notifications With Smartphone–Compatible Diabetes Devices
App notifications can be effected by various notification focuses, software updates, or connecting hardware, such as car audio or wireless earphones.
Benefits of Incorporating Biosimilars Into Health System Formularies
Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at the Mayo Clinic, discusses key benefits of incorporating biosimilars into a health system's formulary.
Q&A: Challenges Pharmacists Face in Assessing, Addressing Health Literacy
Karissa Kim, PharmD, BCPS, BCACP, discusses the main challenges pharmacists face in assessing and addressing patients’ health literacy levels.
Heart Disease Remains Leading Cause of Death in US
The prevalence of high blood pressure is highest in Mississippi at 40.2% compared with the lowest in Colorado at 24.6%.
Premature, Early Menopause Associated with Increased Risk of T2D
Researchers conducted a population-based study of women in Korea to analyze the association between age at menopause and incidence of type 2 diabetes.
FDA Grants ADI-001 Fast Track Designation as Treatment of Refractory Systemic Lupus Erythematosus
ADI-001 is an investigation allogeneic gamma delta chimeric antigen receptor T cell therapy that targets CD20 for the treatment of a variety of autoimmune diseases.
FDA Grants ABO-101 Orphan Drug, Rare Pediatric Disease Designations for PH1
Primary hyperoxaluria type 1 (PH1) is a rare genetic condition that affects the kidney, bladder, or urinary tract, and indicates high levels of oxalates in the urine.
